Literature DB >> 24306268

A meta-analysis of the relationship between aspartic acid (D)-repeat polymorphisms in asporin and osteoarthritis susceptibility.

Gwan Gyu Song1, Jae-Hoon Kim, Young Ho Lee.   

Abstract

Our aim was to determine whether asporin (ASPN) D-repeat polymorphisms are associated with susceptibility to osteoarthritis (OA). A meta-analysis was conducted to examine the association between the ASPN D14, D13, and D15 alleles and OA of the knee and hip in each ethnic group. In total, 9 studies from eight articles involving 4,417 OA patients and 3,403 controls were considered in the meta-analysis. Meta-analysis showed no association between OA and the ASPN allele coding for 14 D-repeats (D14) in the overall population (OR 1.161, 95 % CI 0.934-1.444, p = 0.178). Stratification by ethnicity identified no association between the ASPN D14 allele and OA in Europeans or Asians (OR 1.035, 95 % CI 0.914-1.173, p = 0.589; OR 1.537, 95 % CI 0.899-2.626, p = 0.116), respectively. However, high heterogeneity was found in Asians (I (2) = 81.2, p = 0.001). Meta-analysis of OA by site showed no association between knee and hip OA and the ASPN D14 allele (OR 1.240, 95 % CI 0.946-1.627, p = 0.119; OR 1.130, 95 % CI 0.767-1.665, p = 0.537). Meta-analysis of D14 versus D13 allele showed the same pattern of OA association as the D14 allele. No association was found between the ASPN D13 and D15 alleles and risk of developing OA by meta-analysis (OR 0.942, 95 % CI 0.840-1.056, p = 0.304; OR 1.050, 95 % CI 0.956-1.154, p = 0.306), respectively. This meta-analysis shows that the ASPN D14, D13, and D15 alleles are not associated with the development of OA in Europeans and Asians. Thus, further study of this relationship is required in homogenous populations because of the heterogeneity of the ASPN D14 allele observed in Asians.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24306268     DOI: 10.1007/s00296-013-2916-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

1.  Twins and the genetic architecture of osteoarthritis.

Authors:  A J MacGregor; T D Spector
Journal:  Rheumatology (Oxford)       Date:  1999-07       Impact factor: 7.580

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 3.  An update on the epidemiology of knee and hip osteoarthritis with a view to prevention.

Authors:  D T Felson; Y Zhang
Journal:  Arthritis Rheum       Date:  1998-08

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

5.  Sex and ethnic differences in the association of ASPN, CALM1, COL2A1, COMP, and FRZB with genetic susceptibility to osteoarthritis of the knee.

Authors:  Ana M Valdes; John Loughlin; Mark Van Oene; Kay Chapman; Gabriela L Surdulescu; Michael Doherty; Tim D Spector
Journal:  Arthritis Rheum       Date:  2007-01

6.  Mechanisms for asporin function and regulation in articular cartilage.

Authors:  Masahiro Nakajima; Hideki Kizawa; Masao Saitoh; Ikuyo Kou; Kohei Miyazono; Shiro Ikegawa
Journal:  J Biol Chem       Date:  2007-09-07       Impact factor: 5.157

7.  Aspartic acid repeat polymorphism of the asporin gene with susceptibility to osteoarthritis of the knee in a Korean population.

Authors:  Jae Hwi Song; Hwa Sung Lee; Chang Jae Kim; Yong Gu Cho; Yong Gyu Park; Suk Woo Nam; Jung Young Lee; Won Sang Park
Journal:  Knee       Date:  2008-02-21       Impact factor: 2.199

8.  The D-repeat polymorphism in the ASPN gene and primary knee osteoarthritis in a Mexican mestizo population: a case-control study.

Authors:  R D Arellano; F Hernández; C A García-Sepúlveda; V M Velasco; C R Loera; J R Arguello
Journal:  J Orthop Sci       Date:  2013-06-04       Impact factor: 1.601

9.  Meta-analysis of association between the ASPN D-repeat and osteoarthritis.

Authors:  Takahiro Nakamura; Dongquan Shi; Maria Tzetis; Julio Rodriguez-Lopez; Yoshinari Miyamoto; Aspasia Tsezou; Antonio Gonzalez; Qing Jiang; Naoyuki Kamatani; John Loughlin; Shiro Ikegawa
Journal:  Hum Mol Genet       Date:  2007-05-20       Impact factor: 6.150

10.  PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis.

Authors:  Young Ho Lee; Young Hee Rho; Seong Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2007-01-31       Impact factor: 3.580

View more
  5 in total

1.  Genetic Contribution to the Development of Radiographic Knee Osteoarthritis in a Population Presenting with Nonacute Knee Symptoms a Decade Earlier.

Authors:  Kasper Huétink; Paul van der Voort; Johan L Bloem; Rob G H H Nelissen; Ingrid Meulenbelt
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2016-04-28

2.  Association of aspartic acid repeat polymorphism in the asporin gene with osteoarthritis of knee, hip, and hand: A PRISMA-compliant meta-analysis.

Authors:  Xiaoyue Zhu; Liying Jiang; Yihua Lu; Chunli Wang; Shuai Zhou; He Wang; Tian Tian
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

3.  Genetic polymorphism in the asporin gene is not a key risk factor for osteoarthritis: Evidence based on an updated cumulative meta-analysis.

Authors:  Jing Wang; Aimin Yang; Jie Zhang; Na Sun; Xiangwen Li; Xinghui Li; Qiling Liu; Jun Li; Xiaomei Ren; Zunhua Ke; Rongqiang Zhang
Journal:  Exp Ther Med       Date:  2018-02-26       Impact factor: 2.447

4.  An updated meta-analysis of the asporin gene D-repeat in knee osteoarthritis: effects of gender and ethnicity.

Authors:  Ruoxi Liu; Xueling Yuan; Jing Yu; Qi Quan; Haoye Meng; Cheng Wang; Aiyuan Wang; Quanyi Guo; Jiang Peng; Shibi Lu
Journal:  J Orthop Surg Res       Date:  2017-10-11       Impact factor: 2.359

Review 5.  Association between the aspartic acid D-repeat polymorphisms and osteoarthritis susceptibility: An updated systematic review and meta-analyses.

Authors:  Honglin Wang; Xu Zhang; Wentao Wu; Mingyue Zhang; Napoleon Bellua Sam; Lei Niu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.